Subscribe
Rapid Reactions

Rapid Reactions

IMerge Clinical Data in Patients With Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to Erythropoiesis-Stimulating Agents
Rapid Reactions
Videos
Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, explores imetelstat trial results of patients with transfusion-dependent lower-risk myelodysplastic syndromes who experience failure to or are ineligible for treatment with erythropoiesis-stimulating agents. Read More ›
COMMANDS Study Results May Shift the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes
Rapid Reactions
Videos
Please join Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, as he discusses how the clinical benefits of luspatercept could lead to a new standard of care for patients with transfusion-dependent lower-risk myelodysplastic syndromes. Read More ›

Page 2 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, TON print publication, and TON Bi-Weekly e‑newsletter.

Subscribe

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?